| Recruiting | A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclero Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 / Phase 3 | 2025-10-26 |
| Recruiting | A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants Carcinoma, Non-Small-Cell Lung | Phase 1 | 2025-10-14 |
| Withdrawn | A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer Platinum-resistant Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 1 / Phase 2 | 2025-01-31 |
| Recruiting | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema Diabetic Macular Edema (DME) | Phase 3 | 2024-10-09 |
| Terminated | A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Partic Carcinoma, Non-Small-Cell Lung | Phase 3 | 2024-07-19 |
| Recruiting | A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Effic Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-05-08 |
| Active Not Recruiting | A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficac Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-04-12 |
| Terminated | BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced Endometrial Cancer | Phase 2 / Phase 3 | 2024-04-09 |
| Unknown | Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Pati Advanced Solid Tumor | Phase 1 | 2024-03-06 |
| Recruiting | BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer Cervical Cancer | Phase 2 / Phase 3 | 2023-12-13 |
| Active Not Recruiting | Evaluate the Safety, Tolerability of BAT6026 Dermatitis, Atopic | Phase 1 / Phase 2 | 2023-11-09 |
| Completed | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Sub Healthy Male Subjects | Phase 1 | 2023-11-05 |
| Completed | A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of Healthy Men | Phase 1 | 2023-08-29 |
| Active Not Recruiting | A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders Optic Neuromyelitis Spectrum Disease | Phase 2 | 2023-08-01 |
| Unknown | A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection Healthy Men | Phase 1 | 2023-06-01 |
| Completed | Clinical Study of Stage IV Psoriasis in Children With Geleli Plaque Psoriasis | — | 2023-04-05 |
| Completed | Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Advanced or Metastatic Solid Tumors | Phase 1 | 2023-02-10 |
| Terminated | To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Soli Advanced Solid Tumors | Phase 1 | 2023-01-17 |
| Recruiting | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection Advanced Solid Tumors | Phase 1 | 2022-11-30 |
| Completed | Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients Plaque Psoriasis | Phase 3 | 2022-10-26 |
| Completed | Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects Severe Asthma | Phase 1 | 2022-09-20 |
| Unknown | Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 Locally Advanced/Metastatic Solid Tumours | Phase 1 | 2022-08-02 |
| Completed | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® Psoriatic Arthritis | Phase 1 | 2022-08-01 |
| Completed | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration Neovascular (Wet) Age-related Macular Degeneration | Phase 3 | 2022-07-07 |
| Completed | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection Advanced Solid Tumors | Phase 1 | 2022-07-06 |
| Completed | Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects SARS-CoV-2 Infection | Phase 1 | 2022-06-09 |
| Completed | Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects Psoriasis | Phase 1 | 2022-06-08 |
| Completed | BAT7104 in Patients With Advanced Solid Tumours Patients With Advanced Solid Tumors | Phase 1 | 2022-04-29 |
| Terminated | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients Advanced Solid Tumour | Phase 1 | 2022-02-28 |
| Terminated | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China Solid Tumor | Phase 1 | 2022-02-17 |
| Completed | Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 Advanced Solid Tumor | Phase 1 | 2022-02-10 |
| Completed | BAT7104 Injection in Patients With Advanced Malignant Tumors. Advanced Malignant Tumor | Phase 1 | 2022-01-20 |
| Active Not Recruiting | Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) Uveitis | Phase 4 | 2021-12-27 |
| Completed | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China Advanced Solid Tumors | Phase 1 | 2021-12-23 |
| Completed | Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2021-11-12 |
| Terminated | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients Advanced Solid Tumor | Phase 1 | 2021-10-29 |
| Completed | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors Advanced Solid Tumor, Melanoma | Phase 1 | 2021-09-02 |
| Completed | Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2021-07-06 |
| Completed | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2021-05-06 |
| Withdrawn | A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients COVID-19 | Phase 1 / Phase 2 | 2020-10-20 |
| Completed | Clinical Study of the Safety and Efficacy of BAT5906 Injection Diabetic Macular Edema | Phase 1 / Phase 2 | 2020-10-16 |
| Completed | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2020-09-17 |
| Completed | A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders Neuromyelitis Optica Spectrum Disorders | Phase 1 | 2020-09-01 |
| Completed | Clinical Study on the Efficacy and Safety of BAT5906 Injection Wet Age-related Macular Degeneration | Phase 2 | 2020-08-26 |
| Completed | Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects Psoriasis | Phase 1 | 2020-08-08 |
| Completed | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects Psoriatic Arthritis | Phase 1 | 2019-09-09 |
| Unknown | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor Solid Tumor | Phase 1 / Phase 2 | 2019-06-21 |
| Terminated | Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer Advanced Solid Cancer | Phase 1 | 2019-03-15 |
| Completed | Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methot Rheumatoid Arthritis | Phase 3 | 2018-12-19 |
| Completed | A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration Age-related Macular Degeneration | Phase 1 | 2018-10-30 |
| Completed | A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients Non-Hodgkin's Lymphoma | Phase 1 | 2018-09-04 |
| Unknown | The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer HER2-positive Advanced Breast Cancer | Phase 3 | 2018-07-01 |
| Completed | Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects Rheumatoid Arthritis | Phase 1 | 2018-06-13 |
| Completed | A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Canc Non-squamous Non-small Cell Lung Cancer | Phase 3 | 2017-10-20 |
| Unknown | A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients HER2-Positive Solid Tumors | Phase 1 | 2017-03-07 |
| Completed | A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira Ankylosing Spondylitis | Phase 3 | 2016-12-13 |
| Completed | Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects NSCLC | Phase 1 | 2016-03-15 |